This company has been marked as potentially delisted and may not be actively trading. Elicio Therapeutics (ELTX) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Elicio Therapeutics (NASDAQ:ELTX)CurrentInstitutional OwnershipPercentage35.03%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$1.07MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$50K Get ELTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Elicio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ELTX Institutional Buying and Selling by Quarter Elicio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 Raymond James Financial Inc.6,000$46K0.0%N/A0.037% 8/8/2025 Geode Capital Management LLC120,831$933K0.0%+56.0%0.755% 8/4/2025 Mayflower Financial Advisors LLC10,000$77K0.0%N/A0.063% 5/19/2025 Jane Street Group LLC14,993$92K0.0%N/A0.139% 5/15/2025 Royal Bank of Canada36,537$225K0.0%N/A0.339% 5/9/2025 CM Management LLC55,000$339K0.3%+37.5%0.510% 4/28/2025 Moody Lynn & Lieberson LLC10,000$62K0.0%N/A0.093% 2/7/2025 CM Management LLC40,000$204K0.2%-20.0%0.371% 8/15/2024 Armistice Capital LLC100,000$411K0.0%N/A0.978% 8/9/2024 Warberg Asset Management LLC11,801$49K0.0%N/A0.115% 8/2/2024 CM Management LLC50,000$206K0.2%-33.3%0.489% 5/14/2024 CM Management LLC75,000$570K0.5%+50.0%0.733% 8/4/2023 CM Management LLC65,000$618K0.6%N/A2.159% (Data available from 1/1/2016 forward) ELTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELTX shares? During the previous two years, 9 institutional investors and hedge funds held shares of Elicio Therapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($933K), Armistice Capital LLC ($411K), CM Management LLC ($339K), Royal Bank of Canada ($225K), Jane Street Group LLC ($92K), Mayflower Financial Advisors LLC ($77K), and Moody Lynn & Lieberson LLC ($62K).Learn more on Elicio Therapeutics' institutional investors. What percentage of Elicio Therapeutics' stock is owned by institutional investors? 35.03% of Elicio Therapeutics' stock is owned by institutional investors. Learn more on ELTX's institutional investor holdings. Which institutional investors have been buying Elicio Therapeutics' stock? Of the 9 institutional investors that purchased Elicio Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($100K), Geode Capital Management LLC ($43.36K), CM Management LLC ($40K), Royal Bank of Canada ($36.54K), Jane Street Group LLC ($14.99K), Warberg Asset Management LLC ($11.80K), and Mayflower Financial Advisors LLC ($10K). How much institutional buying is happening at Elicio Therapeutics? Institutional investors have bought a total of 135,894 shares in the last 24 months. This purchase volume represents approximately $1.07M in transactions. Which of Elicio Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Elicio Therapeutics stock in the last 24 months: CM Management LLC ($10K). How much institutional selling is happening at Elicio Therapeutics? Institutional investors have sold a total of 10,000 shares in the last 24 months. This volume of shares sold represents approximately $50K in transactions. Related Companies DNTH Institutional Ownership PHAT Institutional Ownership GYRE Institutional Ownership NRIX Institutional Ownership MNMD Institutional Ownership FTRE Institutional Ownership DAWN Institutional Ownership IMTX Institutional Ownership DNA Institutional Ownership ABUS Institutional Ownership This page (NASDAQ:ELTX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elicio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elicio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access